October 20, 2015 / 12:15 PM / 2 years ago

BRIEF-Cytotools successfully places capital increase

Oct 20 (Reuters) - Cytotools AG

* Successfully places capital increase and creates the prerequisite for the extension of clinical development in the USA

* Gross proceeds in the amount of 4.0 million euro ($4.55 million) ensures expansion of clinical trials in the USA for the wound healing drug DermaPro Source text for Eikon: Further company coverage: ($1 = 0.8794 euros) (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below